# Application of mRNA Vaccine in Liver Transplantation for Hepatocellular Carcinoma

> **NCT07077356** · PHASE1 · RECRUITING · sponsor: **West China Hospital** · enrollment: 15 (estimated)

## Conditions studied

- Hepatocellular Carcinoma (HCC)

## Interventions

- **BIOLOGICAL:** HBV mRNA vaccine

## Key facts

- **NCT ID:** NCT07077356
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07077356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07077356, "Application of mRNA Vaccine in Liver Transplantation for Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07077356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*